Non-Small Cell Lung Cancer — Targeting KRAS G12C

Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:

Introduction (0:00)

Best Option for Your Patient (1:28)

Biological Considerations (6:26)

KRAS G12C Inhibitors (11:33)

Second-Line Treatment (13:02)

Current Clinical Trials in the First-Line Metastatic Setting (32:18)

Current Clinical Trials in the Localized Setting (49:52)

Current Clinical Trials with New Treatment Combinations and Agents (53:51)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.